MICKEY BROWN: Open Payments
NPI 1295139509 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 16 payments from 8 companies in 2025. Trend: 2023 $234 · 2024 $178 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $59 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
| SPR Therapeutics, Inc | 5 | $48 |
| Averitas Pharma Inc. | 1 | $17 |
| Boston Scientific Corporation | 1 | $16 |
| Spinal Simplicity, LLC | 1 | $15 |
| SCILEX PHARMACEUTICALS INC. | 1 | $14 |
Products named: XTAMPZA, RELISTOR, SPRINT PNS System, UBRELVY, BOTOX, QUTENZA, General - Pain Management, HA MINUTEMAN G3-R.
Industry payments across AL — which companies pay providers there.
